Skip to content
Screener

TransMedics Group, Inc. TMDX EV / EBITDA

EV / EBITDA at other companies

CareDx logo
CareDxCDNA
9.6×—
LivaNova logo
LivaNovaLIVN
18.1×+6.9×
ICU Medical logo
ICU MedicalICUI
17.1×+1.5×
Edwards Lifesciences logo
Edwards LifesciencesEW
29.5×+4.1×
OSI Systems logo
OSI SystemsOSIS
19.6×+5.0×

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.78B-31.3%
Enterprise value$2.73B-26.6%
P/E16.2×-40.3×
P/S4.4×-3.2×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%—

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Calculated from TransMedics Group, Inc.’s reported figures.

enterprise value/ebitda=26.4×

Based on the most recent quarter.

The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026. Open the filing →

Filed
May 5, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206453

FAQ

What is TransMedics Group, Inc.'s EV / EBITDA?
TransMedics Group, Inc. (TMDX) reported EV / EBITDA of 26.4× in Q1 2026.
How has TransMedics Group, Inc.'s EV / EBITDA changed year-over-year?
TransMedics Group, Inc.'s EV / EBITDA decreased by 3.4% year-over-year, from 27.3× to 26.4×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about TransMedics Group, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude